What does a VAF (Variant Allele Frequency) of 0.15% mean

Understanding Variant Allele Frequency (VAF) of 0.15%

Great question! VAF is an important concept for understanding what your genetic test results mean. Let me break this down:

What VAF Measures

Variant Allele Frequency tells you what percentage of your cancer cells carry a specific mutation. Think of it like this:

• If you have 1,000 cancer cells in a blood sample, a VAF of 0.15% means roughly 1-2 cells out of 1,000 have that particular mutation
• It's a measure of how common (or rare) that mutation is within your tumor population

What 0.15% Means Clinically

A VAF of 0.15% is very low — this is important context:

✅ What it suggests:

• The mutation is present but extremely rare in your circulating tumor DNA (ctDNA)
• It may represent a minor clone — a small subpopulation of cancer cells with this mutation
• It could indicate early emergence of a mutation that might become more dominant later

⚠️ Clinical interpretation challenges: According to expert guidance from CancerPatientLab webinars on molecular tumor boards, when VAF is this low, oncologists must consider:

• Is this truly actionable? Experts note that mutations with VAF around 25% or higher are generally considered actionable for treatment decisions
• Detection vs. reality: A low VAF could mean the mutation is genuinely rare in your tumor, OR it could reflect the limits of the test's sensitivity

Questions to Ask Your Oncologist

Since 0.15% is borderline detectable, ask your care team:

1. "Is this mutation considered actionable for treatment decisions, or is it below the clinical threshold?"
2. "Should we retest in the future to see if this VAF is increasing over time?" (Rising VAF can signal emerging resistance)
3. "What's the clinical significance of this specific mutation in my cancer type?"
4. "Does this change my surveillance plan or treatment approach?"

Important Context

According to CancerPatientLab expert discussions, when interpreting low VAF mutations:

• Variant allele fraction helps identify which mutations are most abundant and should be targeted first
• A mutation at 0.15% would typically be addressed after any mutations with higher VAF
• Serial monitoring (testing over time) is often more informative than a single result, especially for low-frequency mutations

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.